This from their 10Q back on 6/21 • We have als
Post# of 36536
(Total Views: 386)
Posted On: 02/14/2022 4:06:50 PM
This from their 10Q back on 6/21
• We have also obtained a new order for Excellagen in a NYC Hospital that recently cleared us through the Value Analysis Committee.
• In addition, Mount Sinai Hospital is in the process of completing their quality study of 10 patients using Excellagen in post OR debridement cases, preliminary results have been “extremely positive”.
• We have also obtained a new order for Excellagen in a NYC Hospital that recently cleared us through the Value Analysis Committee.
• In addition, Mount Sinai Hospital is in the process of completing their quality study of 10 patients using Excellagen in post OR debridement cases, preliminary results have been “extremely positive”.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼